Fasicularin
FULL PAPER
raphy (ethyl acetate/hexanes 1:15) afforded a clear oil (10.8 mg, 60%).
[a]2D6:5 =+66.9 (c = 0.187 in CHCl3); 1H NMR (400 MHz, CDCl3): d=
7.71 (d, J=8.2 Hz, 2H), 7.24 (d, J=7.9 Hz, 2H), 5.79–5.73 (m, 1H), 5.57–
5.50 (m, 3H), 4.09 (dd, J=9.2, 5.5 Hz, 1H), 3.82 (dd, J=12.8, 5.5 Hz,
1H), 2.93 (dd, J=12.8, 9.2 Hz, 1H), 2.39 (s, 3H), 2.21 (ddd, J=12.8, 11.9,
3.7 Hz, 1H), 2.12–2.01 (m, 1H), 2.00–1.88 (m, 2H), 1.78–1.68 (m, 1H),
1.67–1.53 (m, 1H); 13C NMR (75 MHz, CDCl3): d = 142.9, 139.6, 133.7,
130.3, 129.3, 128.8, 128.1, 127.4, 65.1, 60.4, 47.6, 32.6, 25.7, 24.1, 21.4, 19.7,
18.1, ꢀ4.8, ꢀ4.9; IR (KBr): n˜ =2931, 2859, 1340, 1163 cmꢀ1; LRMS (CI,
ammonia): m/z (%): 434 (49) [M+H]+.
Compound 30: [a]2D0:4 =ꢀ22.37 (c
=
0.152 in CHCl3); 1H NMR
(400 MHz, CDCl3): d
= 3.57–3.47 (m, 2H), 2.77 (ddd, J=12.2, 4.6,
1.2 Hz, 1H), 2.55 (dd, J=12.2, 8.9 Hz, 1H), 2.09–1.99 (m, 1H), 1.82–1.65
(m, 3H), 1.63–1.15 (m, 20H), 1.06–0.96 (m, 3H), 0.87–0.83 (m, 12H),
0.02 (s, 3H), 0.01 (s, 3H); 13C NMR (75 MHz, CDCl3): d = 72.6, 69.3,
52.6, 47.6, 44.3, 37.5, 36.8, 32.5, 31.8, 30.6, 29.7, 29.4, 26.8, 25.9, 25.6, 24.3,
22.6, 21.2, 18.1, 14.1, ꢀ4.6; IR (CCl4): n˜ =3628, 3368, 2859 cmꢀ1; HRMS
(EI): m/z: calcd for C25H51NO2Si: 425.3689; found: 425.3697.
Amine 31: To a cold (08C) solution of (+)-(3S)-1-[(3S,6R,7R)-3-(tert-bu-
tyldimethylsilyloxy)-1-azaspiro[5.5]undec-7-yl]-nonan-3-ol (29) (36.7 mg,
0.0862 mmol, 1.0 equiv) and triphenylphosphine (74.6 mg, 0.284 mmol,
3.3 equiv) in dichloromethane (2.5 mL) was added carbon tetrabromide
(94.3 mg, 0.284 mmol, 3.3 equiv) followed by the addition of triethyl-
amine (40 mL, 0.287 mmol, 3.3 equiv). The pale yellow solution was al-
lowed to warm to RT and stirred for 5 h. The solvent was removed by
evaporation in vacuo. Purification by column chromatography (diethyl
ether/petroleum ether 1:4; 2% ammonium hydroxide) on silica gel af-
forded a clear oil (29.6 mg, 84%). [a]2D0:8 =+4.51 (c = 0.265 in CHCl3);
1H NMR (400 MHz, CDCl3): d=3.95–3.86 (m, 1H), 2.97–2.82 (m, 3H),
2.63 (d, J=13.1 Hz, 1H), 1.84–1.47 (m, 1H), 1.40–1.10 (m, 17H), 1.03–
0.93 (m, 1H), 0.86 (s, 12H), 0.02 (s, 6H); 13C NMR (75 MHz, CDCl3):
d=62.5, 56.6, 53.5, 47.3, 45.9, 34.5, 34.2, 32.6, 31.8, 30.0, 29.9, 29.8, 27.2,
26.2, 25.9, 25.4, 22.8, 22.6, 18.2, 17.5, 14.1, ꢀ4.6; IR (CCl4): n˜ =2929, 2860,
1464, 1092 cmꢀ1; HRMS (EI): m/z: calcd for C25H49NOSi: 407.3583;
found: 407.3579.
Amine 24: Lithium (12.9 mg, 1.86 mmol, 29 equiv) was washed three
times with HPLC grade pentane and dissolved in ammonia (10 mL) at
ꢀ788C. A solution of 22b (44.4 mg, 0.0638 mmol, 1.0 equiv) in THF
(3.0 mL) was added. The mixture was stirred for 10 min at ꢀ788C and
quenched by the dropwise addition of methanol. A saturated solution of
aqueous ammonia chloride was added and the mixture was allowed to
warm to RT while open to the atmosphere to allow the ammonia to evap-
orate. The two layers were separated and the aqueous layer was extract-
ed with diethyl ether. The combined organic layers were dried over mag-
nesium sulfate, filtered, and the solvent was evaporated in vacuo. Purifi-
cation by column chromatography (diethyl ether/petroleum ether 1:2) on
silica gel yielded a clear oil (22.4 mg, 83%). [a]1D9:8 =+72.3 (c = 0.213 in
CHCl3); 1H NMR (400 MHz, CDCl3): d
= 5.67 (d, J=10.4 Hz, 1H),
5.60–5.55 (m, 1H), 5.25 (dd, J=10.4, 2.1 Hz, 1H), 4.33–4.26 (m, 1H),
3.52–3.42 (m, 1H), 2.99 (ddd, J=10.7, 5.8, 1.2 Hz, 1H), 2.66 (dd, J=10.7,
9.2 Hz, 1H), 2.14–1.87 (m, 6H), 1.69–1.61 (m, 1H), 1.60–1.49 (m, 1H),
1.47–1.18 (m, 12H), 0.86–0.81 (m, 3H), 0.84 (s, 9H), 0.04 (s, 3H), 0.03 (s,
3H); 13C NMR (75 MHz, CDCl3): d = 139.5, 134.0, 131.9, 125.3, 67.2,
65.8, 55.9, 46.3, 37.2, 36.6, 31.8, 31.8, 29.5, 26.0, 25.8, 25.4, 25.1, 22.6, 18.9,
18.0, 14.0, ꢀ4.6, ꢀ4.7; IR (CCl4): n˜ =3284, 2930, 2858, 1109 cmꢀ1; LRMS
(CI, ammonia): m/z (%): 422 (100) [M+H]+, 421 (8) [M]+.
Alcohol 32: A solution of silyl ether 31 (40.0 mg, 0.0981 mmol, 1.0 equiv)
in THF (5.0 mL) was added to a round bottom containing powdered acti-
vated 4 ꢃ molecular sieves (500 mg). Tetrabutylammonium fluoride, pre-
treated with 4 ꢃ molecular sieves, (300 mL, 0.300 mmol, 3.1 equiv) was
added and the mixture was stirred at RT for 0.5 h. The reaction was fil-
tered and the solvent removed by evaporation in vacuo. Purification by
gradient column chromatography (diethyl ether!diethyl ether/methanol
19:1; 2% ammonium hydroxide) afforded a white solid (23.7 mg, 82%).
Tricyclic amine 25: To a cold (08C) solution 24 (129 mg, 0.306 mmol,
1.0 equiv) and triphenylphosphine (160 mg, 0.612 mmol, 2.0 equiv) in di-
chloromethane (6.0 mL) was added carbon tetrabromide (203 mg,
0.612 mmol, 2.0 equiv) followed by the addition of triethylamine (85 mL,
0.610 mmol, 2.0 equiv). The pale yellow solution turned red as it was al-
lowed to warm to RT and stirred for 0.5 h. The solvent was removed by
evaporation in vacuo. Purification by column chromatography (diethyl
ether/petroleum ether 1:11) on silica gel afforded a pale yellow oil
M.p. 69–718C (ethyl acetate/hexanes); [a]2D0:3 =+4.2 (c
= 0.259 in
CHCl3); 1H NMR (400 MHz, CDCl3):d = 3.99–3.87 (m, 1H), 3.07 (ddd,
J=14.4, 4.6, 1.8 Hz, 1H), 2.90–2.80 (m, 2H), 2.57 (d, J=13.1 Hz, 1H),
1.95–1.47 (m, 8H), 1.41–0.96 (m, 18H), 0.85 (t, J=6.7 Hz, 3H); 13C NMR
(75 MHz, CDCl3): d = 61.8, 56.7, 53.5, 47.1, 45.8, 34.5, 34.0, 32.5, 31.9,
29.9, 29.7, 27.1, 26.1, 25.5, 22.7, 22.6, 17.4, 14.1; IR (CCl4): n˜ =3084, 2925,
2860, 1469, 1083 cmꢀ1
.
(113 mg, 92%). [a]2D1:7 =+120.2 (c
=
0.205 in CHCl3); 1H NMR
Alcohol 33: A solution of alcohol 32 (22.9 mg, 0.0780 mmol, 1.0 equiv) in
dichloromethane (2.5 mL) was added to a round bottom containing pow-
dered activated 4 ꢃ molecular sieves (83 mg). Tetrapropylammonium
perruthenate (3.1 mg, 0.0088 mmol, 0.11 equiv) was added in one portion.
The mixture was cooled to 08C and 4-methylmorpholine N-oxide
(12.9 mg, 0.110 mmol, 1.4 equiv) was added in one portion. The mixture
was warmed to RT, stirred for 2 h, filtered through Celite, and the solvent
was removed by evaporation in vacuo. Purification by column chroma-
tography (diethyl ether/hexanes 1:1) on silica gel afforded a clear oil
(400 MHz, CDCl3): d 5.77 (dd, J=10.4, 1.5 Hz, 1H), 5.68 (d, J=
=
10.4 Hz, 1H), 5.43–5.39 (m, 1H), 4.40–4.32 (m, 1H), 3.18 (ddd, J=14.4,
6.2, 1.0 Hz, 1H), 3.10 (dd, J=14.4, 9.9 Hz, 1H), 2.74–2.66 (m, 1H), 2.38–
2.30 (m, 1H), 2.06–1.88 (m, 4H), 1.77–1.58 (m, 5H), 1.54–1.08 (m, 10H),
0.90–0.84 (m, 12H), 0.89 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H); 13C NMR
(75 MHz, CDCl3): d = 139.2, 16.5, 129.6, 122.1, 60.7, 57.9, 55.5, 47.7,
39.9, 34.3, 32.4, 32.1, 31.8, 29.9, 26.0, 25.3, 25.2, 22.6, 20.2, 18.3, 14.1, ꢀ4.5,
ꢀ4.6; IR (CCl4): n˜ =3084, 2931, 2859, 1519, 1250 cmꢀ1; LRMS (CI, am-
monia): m/z (%): 404 (100) [M+H]+, 403 (5) [M]+.
(18.0 mg, 79%). [a]2D1:2 =+102.6 (c
=
0.178 in CHCl3); 1H NMR
Alcohol 29: Alkene 24 (143.9 mg, 0.341 mmol, 1.0 equiv) and Rh/C 5
wt% on carbon (141 mg, 0.0684 mmol, 0.20 equiv) were dissolved in eth-
anol (17 mL). The mixture was stirred under 1 atm H2 at RT for 24 h.
The mixture was filtered through Celite and the solvent was removed by
evaporation in vacuo. Purification by gradient column chromatography
(ethyl acetate/hexanes 1:2 ! ethyl acetate) on silica gel afforded (ꢀ)-
(3S)-1-[(3S,6R,7S)-3-(tert-butyldimethylsilyloxy)-1-azaspiro[5.5]undec-7-
(400 MHz, CDCl3): d=3.95–3.86 (m, 1H), 2.97–2.82 (m, 3H), 2.63 (d, J=
13.1 Hz, 1H), 1.84–1.47 (m, 1H), 1.40–1.10 (m, 17H), 1.03–0.93 (m, 1H),
0.86 (s, 12H), 0.02 (s, 6H); 13C NMR (75 MHz, CDCl3): d=213.3, 56.5,
54.8, 53.6, 45.1, 35.8, 34.1, 33.8, 32.2, 31.8, 29.7, 26.8, 25.9, 24.7, 23.2, 22.6,
20.1, 14.0; IR (CCl4): n˜ =2931, 2861, 1719 cmꢀ1
To
.
a
cold (ꢀ788C) solution of (+)-(1R,7R,10R)-7-hexyl-6-azatricy-
clo[8.4.0.01,6]tetradecan-4-one (11.2 mg, 0.0384 mmol, 1.0 equiv) in THF
(1.9 mL) was added l-Selectride (25 mL, 0.0250 mmol, 1.7 equiv) and the
mixture was stirred at ꢀ788C for 1 h. 3n Sodium hydroxide (0.48 mL)
was added followed by the addition of 30% hydrogen peroxide
(0.42 mL). The mixture was warmed to RT and poured into a saturated
solution of aqueous potassium sodium tartrate. The two layers were sepa-
rated and the aqueous layer was extracted with dichloromethane. The
combined organic layers were dried over magnesium sulfate, filtered, and
the solvent was evaporated in vacuo. Purification by gradient column
chromatography (diethyl ether/methanol 19:1! diethyl ether/methanol
9:1; 1% ammonium hydroxide) on silica gel yielded a clear oil (7.5 mg,
67%). 1H NMR (400 MHz, CDCl3): d=3.77 (s, 1H), 3.43–3.33 (m, 1H),
yl]-nonan-3-ol (30) as
a clear oil (9.6 mg, 6.6%) and (+)-(3S)-1-
[(3S,6R,7R)-3-(tert-butyldimethylsilyloxy)-1-azaspiro[5.5]undec-7-yl]-
nonan-3-ol (29) as a clear oil (99.7 mg, 69%).
Compound 29: [a]2D0:7 =+31.60 (c
=
0.201 in CHCl3); 1H NMR
(400 MHz, CDCl3): d 3.59–3.44 (m, 2H), 2.80 (ddd, J=11.6, 5.5,
=
4.9 Hz, 1H), 2.69 (dd, J=11.6, 10.1 Hz, 1H), 2.28–2.19 (m, 1H), 1.78–
1.51 (m, 6H), 1.48–0.82 (m, 32H), 0.02 (s, 3H), 0.01 (s, 3H); 13C NMR
(75 MHz, CDCl3): d = 70.3, 69.9, 53.3, 48.0, 46.1, 37.6, 35.9, 32.6, 31.8,
29.8, 29.4, 28.3, 25.8, 25.3, 25.1, 24.6, 22.6, 18.1, 14.1, ꢀ4.6; IR (CCl4): n˜ =
3255, 3148, 2929, 2857, 1456, 1361, 1110 cmꢀ1; HRMS (EI): m/z: calcd for
C25H51NO2Si: 425.3689; found: 425.3691.
Chem. Eur. J. 2005, 11, 639 – 649
ꢁ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
647